Runmaide medical passed the hearing: Ping An capital was a shareholder with a loss of 630million during the year

RedI network Lei Jianping 6 month 21 Reported Wednesday

Runmaide Medical Co., Ltd （ abbreviation ：“ Runmaide Medical ”） Recently passed the hearing , Ready to list in Hong Kong .

Loss during the year 6.34 Billion

Runmaide Medical Co., Ltd 2014 Founded in , Is a medical device company , The current focus is on the fractional flow reserve system for coronary angiography （「caFFR System 」） And coronary angiography microvascular resistance index system （「caIMR System 」） The design of the 、 Development and commercialization .

The core product of runmaide Medical caFFR System and caIMR The system is a highly innovative medical device , It is used to evaluate coronary artery stenosis and microvascular dysfunction （ Coronary heart disease (CHD) （「CAD」） Related causes of ） The severity of myocardial ischemia , It is intended to replace the use of pressure guide wire , Greatly reduce technical error and operation time , So as to improve the physiological evaluation of coronary artery .

These two systems are currently used separately for CAD Accurate diagnosis of , It is expected to become the core and key module of runmaide medical's future vascular interventional surgery robot .

Runmaide Medical 2020 year 、2021 The annual revenue is 609.7 Ten thousand yuan 、8120 Ten thousand yuan ; The gross profit is 526 Ten thousand yuan 、6903 Ten thousand yuan .

Runmaide Medical 2020 year 、2021 The annual operating losses are 3236 Ten thousand yuan 、1.43 One hundred million yuan ; Losses during the year are 1.45 One hundred million yuan 、6.34 One hundred million yuan .

Runmaide Medical 2021 The fair value loss of financial liabilities included in the year was 4.94 One hundred million yuan .

By 2021 year 12 month 31 Japan , The cash and cash equivalents held by runmaide medical are 5.59 One hundred million yuan .

Ping An capital is a shareholder

The executive directors of runmaide medical are huoyunfei 、 Lvyonghui 、 Zhang liang 、 Ms. Guyang ; The non-executive director is Wang Lin 、 Heng Lei , The independent non-executive directors are liaochuanjiang 、 Lihaomin 、 Liuzihao .

2021 year 10 month , Runmaide medical announced the completion of 7200 Ten thousand dollar financing , Led by Ping An capital, the core private equity platform of China Ping An group , International capital Seresia Asset Management、Lighthouse Canton Wait for the follow-up shot . among , Ping An capital investment 3600 Thousands of dollars , Haihui all profit investment 2400 Thousands of dollars .

IPO front , The huoyunfei family passed Opera Rose Trust The shareholding is 18.77%,Vermilion Bird The shareholding is 13.98%,Light Wisdom HK The shareholding is 4.29%, Tongxianghaogan holds shares of 8.75%;

Hebei dongtuo holds shares of 5.23%, Ping An investment holds 6.29%, Shanghai jingmairun holds shares of 5.15%, The shares held by Haihui Quanli are 4.2%,Mingze The shareholding is 2.7%.

———————————————

Lei Di was founded by Lei Jianping, a senior media person , If reproduced, please indicate the source .